From With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs:

Arthur Hiller, CEO of SciFluor Life Sciences
Arthur Hiller, CEO of SciFluor Life Sciences

Cambridge, MA-based biotech startup working on using fluorine tech to improve follow-on drugs